Thomas Mc Naughton Net Worth

The estimated Net Worth of Thomas Mc Naughton is at least $38.9 mil dollars as of 15 June 2018. Thomas Naughton owns over 2,500 units of Harvard Bioscience stock worth over $38,867 and over the last 16 years Thomas sold HBIO stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Thomas Naughton HBIO stock SEC Form 4 insiders trading

Thomas has made over 2 trades of the Harvard Bioscience stock since 2016, according to the Form 4 filled with the SEC. Most recently Thomas bought 2,500 units of HBIO stock worth $11,000 on 15 June 2018.

The largest trade Thomas's ever made was buying 5,000 units of Harvard Bioscience stock on 20 May 2016 worth over $7,800. On average, Thomas trades about 536 units every 54 days since 2008. As of 15 June 2018 Thomas still owns at least 13,734 units of Harvard Bioscience stock.

You can see the complete history of Thomas Naughton stock trades at the bottom of the page.

What's Thomas Naughton's mailing address?

Thomas's mailing address filed with the SEC is C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746.

Insiders trading at Harvard Bioscience

Over the last 21 years, insiders at Harvard Bioscience have traded over $10,145,146 worth of Harvard Bioscience stock and bought 754,658 units worth $2,380,232 . The most active insiders traders include Earl R Lewis, Bertrand Loy, eDavid Green. On average, Harvard Bioscience executives and independent directors trade stock every 43 days with the average trade being worth of $182,054. The most recent stock trade was executed by James W Green on 13 June 2024, trading 10,000 units of HBIO stock currently worth $29,100.

What does Harvard Bioscience do?

harvard bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. we sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including ge healthcare, thermo fisher scientific inc., and vwr. we have sales and manufacturing operations in the united states, the united kingdom, germany, and spain and sales facilities in france and canada.

Complete history of Thomas Naughton stock trades at Biostage e Harvard Bioscience

Harvard Bioscience executives and stock owners

Harvard Bioscience executives and other stock owners filed with the SEC include:

• James Green,
  Chairman of the Board, President, Chief Executive Officer
• James W. Green,
  Pres, CEO & Chairman
• Kenneth Fletcher Olson,
  Chief Operating Officer
• Michael A. Rossi,
  Chief Financial Officer
• Michael Rossi,
  Chief Financial Officer
• Bertrand Loy,
  Lead Independent Director
• John Kennedy,
  Independent Director
• Alan Edrick,
  Independent Director
• Thomas Loewald,
  Independent Director
• Katherine Eade,
  Independent Director
• Susan Steele,
  Independent Director
• Kenneth Olson,
  Vice President, General Manager - Data Sciences International
• David Sirois,
  Director of Corp. Accounting & SEC Reporting
• Jacques Coumans Ph.D.,
  Chief Marketing Officer
• David Green,
  President
• Earl R Lewis,
  Director
• Robert E. Gagnon,
  Chief Financial Officer
• Neal J Harte,
  Director
• George Uveges,
  Director
• Jeffrey Duchemin,
  Chief Executive Officer
• Yong Sun,
  VP - Strategic Marketing
• Kamalam Unninayar,
  Chief Financial Officer
• David L Strack,
  President of Subsidiary
• Chane Graziano,
  Chief Executive Officer
• Robert A Dishman,
  Director
• Yoav Sibony,
  VP - Global Sales
• Thomas Mc Naughton,
  Chief Financial Officer
• Mark A Norige,
  Chief Operating Officer
• Paul Bailey,
  Vice President Finance
• Bryce Anthony Chicoyne,
  Chief Financial Officer
• Advisors Llc Nelson Kerry S...,
  
• Limited Partnership Hso,
  10% owner
• Susan M Luscinski,
  Chief Financial Officer
• Yash Singh,
  Executive Vice President
• Jennifer Cote,
  Chief Financial Officer